An outbreak of Fusarium solani endophthalmitis after cataract surgery in an eye training and research hospital in Istanbul

Mycoses

Volumn 54, Issue 6, 2011, Pages

  Güngel, Hülya ^a   Eren, Mümin Hakan ^a   Pinarci, Eylem Yaman ^b   Altan, Çiǧdem ^a   Baylançiçek, Deniz Oygar ^c   Kara, Necip ^a   Gürsel, Tanil ^a   Yegenoǧlu, Yildiz ^d   Susever, Serdar ^d  

^a Beyoglu Eye Research and Training Hospital   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c Self employed ophthalmologist   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antifungal treatment; Endophthalmitis; Fusarium solani

Indexed keywords

CEFTAZIDIME; CEFUROXIME AXETIL; MOXIFLOXACIN; PREDNISOLONE ACETATE; VANCOMYCIN;

AGED; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; FEMALE; FUNGAL ENDOPHTHALMITIS; FUSARIUM SOLANI; HUMAN; KERATOPLASTY; MALE; PHACOEMULSIFICATION; PRIORITY JOURNAL; SLIT LAMP; TURKEY (REPUBLIC); VISUAL ACUITY; VITRECTOMY;

AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CATARACT EXTRACTION; CROSS INFECTION; DISEASE OUTBREAKS; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; FEMALE; FUSARIOSIS; FUSARIUM; HOSPITALS; HUMANS; MALE; MIDDLE AGED; SURGICAL WOUND INFECTION; VITRECTOMY;

FUSARIUM SOLANI;

EID: 80053971628     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02019.x     Document Type: Article

References (39)

1. Wong TY, Chee SP. The epidemiology of acute endophthalmitis after cataract surgery in an Asian population. Ophthalmology 2004; 111: 699-705.
2. Aaberg TM Jr, Flynn HW Jr, Schiffman J et al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology 1998; 105: 1004-10.
3. Benz MS, Scott IU, Flynn HW Jr et al. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol 2004; 137: 38-42.
4. Kunimoto DY, Das T, Sharma S et al. Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol 1999; 128: 240-2.
5. Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study: a randomised trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995; 113: 1479-96.
6. Herbrecht R. Voriconazole: therapeutic review of a new azole antifungal. Expert Rev Anti Infect Ther 2004; 2: 485-97.
7. Reis A, Sundmacher R, Tintelnot K et al. Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole. Br J Ophthalmol 2000; 84: 932-3.
8. Sen P, Gopal L, Sen PR. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series. Retina 2006; 25: 935-9.
9. Garg P, Mahesh S, Bansal AK et al. Fungal infection of sutureless self-sealing incision for cataract surgery. Ophthalmology 2003; 110: 2173-7.
10. Ausayakhun S, Itthipunkul N, Patikulsila D et al. An outbreak of acute postoperative endophthalmitis after cataract surgery. J Med Assoc Thai 2008; 91: 1239-43.
11. Callanan D, Scott IU, Murray TG et al. Early onset endophthalmitis caused by Aspergillus species following cataract surgery. Am J Ophthalmol 2006; 142: 509-11.
12. Flynn HW Jr, Scott IU, Brod RD et al. Current management of endophthalmitis. Int Ophthalmol Clin 2004; 44: 115-37.
13. Sunaric-Mégevand G, Pournaras CJ. Current approach to postoperative endophthalmitis. Br J Ophthalmol 1997; 81: 1006-15.
14. Abad JC, Foster CS. Fungal keratitis. Int Ophthalmol Clin 1996; 36: 1-15.
15. Weissgold DJ, Maguire AM, Brucker AJ. Management of postoperative acremonium endophthalmitis. Ophthalmology 1996; 103: 749-56.
16. Savir H, Henig E, Lehrer N. Exogenous mycotic infections of the eye and adnexa. Ann Ophthalmol 1978; 10: 1013-8.
17. Aydin S, Ertugrul B, Gultekin B et al. Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy. BMC Infect Dis 2007; 7: 87.
18. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995; 9: 1-9.
19. Leibovici L, Yehezkelli Y, Porter A et al. Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections. Diabet Med 1996; 13: 457-63.
20. Yildiran ST, Mutlu FM, Saracli MA et al. Fungal endophthalmitis caused by Aspergillus ustus in a patient following cataract surgery. Med Mycol 2006; 44: 665-9.
21. John T, Sims M, Hoffmann C. Intraocular bacterial contamination during sutureless, small incision, single-port phacoemulsification. J Cataract Refract Surg 2000; 26: 1786-91.
22. Wykoff CC, Parrott MB, Flynn HW et al. Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002-2009). Am J Ophthalmol 2010; 150: 392-8.
23. Souri EN, Green WR. Intravitreal amphotericin B toxicity. Am J Ophthalmol 1974; 78: 77-81.
24. O'day DM, Head WS, Robinson RD et al. Intraocular penetration of systemically administered antifungals agents. Curr Eye Res 1985; 4: 131-4.
25. Kuriakose T, Kothari M, Paul P et al. Intracameral amphotericin B injection in the management of deep keratomycosis. Cornea 2002; 21: 653-6.
26. Gallagher JC, MacDougall C, Ashley ES et al. Recent advances in antifungal pharmacotherapy for invasive fungal infections. Expert Rev Anti Infect Ther 2004; 2: 253-68.
27. Ghannoum MA, Kuhn DM. Voriconazole: better chances for patients with invasive mycoses. Eur J Med Res 2002; 7: 242-56.
28. Sanati H, Belanger P, Fratti R et al. A new triazole, voriconazole (UK109, 496), blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob Agents Chemother 1997; 41: 2492-6.
29. Gao H, Pennesi M, Shah K et al. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies. Trans Am Ophthalmol Soc 2003; 101: 183-9.
30. Breit SM, Hariprasad SM, Mieler WF et al. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol 2005; 139: 135-40.
31. Lin RC, Sanduja N, Hariprasad SM. Successful treatment of postoperative fungal endophthalmitis using intravitreal and intracameral voriconazole. J Ocul Pharmacol Ther 2008; 24: 245-8.
32. Thiel MA, Zinkernagel AS, Burhenne J et al. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 2007; 51: 239-44.
33. Vemulakonda GA, Hariprasad SM, Mieler WF et al. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmol 2008; 126: 18-22.
34. Iyer SA, Tuli SS, Wagoner RC. Fungal keratitis: emerging trends and treatment outcomes. Eye Contact Lens 2006; 32: 267-71.
35. Wingard LB Jr, Zuravleff JJ, Doft BH, Berk L, Rinkoff J. Intraocular distribution of intravitreally administered amphotericin B in normal and vitrectomized eyes. Invest Ophthalmol Vis Sci 1989; 30: 2184-9.
36. Aguilar HE, Meredith TA, el-Massry A et al. Vancomycin levels after intravitreal injection. Effects of inflammation and surgery. Retina 1995; 15: 428-32.
37. Gupta A, Gupta V, Gupta A et al. Spectrum and clinical profile of post cataract surgery endophthalmitis in north India. Indian J Ophthalmol 2003; 51: 139-45.
38. Dursun D, Fernandez V, Miller D et al. Advanced Fusarium keratitis progressing to endophthalmitis. Cornea 2003; 22: 300-3.
39. Çakir M, Imamoǧlu S, Çekiç O et al. An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery. Curr Eye Res 2009; 34: 988-95.